---
$id: https://graph.org.ai/products/commodity/51343301
$type: Product
source: UNSPSC
code: "51343301"
title: "Xenazoic acid"
class: "51343300"
classTitle: "Antivirals, synthesized"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Xenazoic acid

**UNSPSC Code**: 51343301
**Class**: [Antivirals, synthesized](Antivirals, synthesized.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiviral agent with the molecular formula C23H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KDU8VH09O8, chemically known as benzoic acid, p-(alpha-ethoxy-p-phenylphenacylamino)- but generally known as xenazoic acid, which bears US NIH Compound Identifier 239062. European Medicines Agency schedules Xenazoic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00101MIG. The term XENAZOIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). Most nations schedule xenazoic acid under HS 29225000 and SITC 51467. As of Q4 2014, XENAZOIC ACID remains the US FDA Preferred Term for this commodity. Xenazoic acid bears US NLM identifiers UMLS ID C1883571 and NCI Concept Code C66662. SMILES: O(C(NC1CCC(CC1)C(=O)O)C(=O)C1CCC(CC1)C1CCCCC1)CC.

